Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Imperial Innovations Group plc
DescriptionNebulized plasmid DNA encoding the cystic fibrosis transmembrane conductance regulator (CFTR) gene complexed with a cationic liposome
Molecular Target Cystic fibrosis transmembrane conductance regulator (CFTR)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Non-viral vector
Latest Stage of DevelopmentPhase II
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation U.S. - Orphan Drug (Treat cystic fibrosis (CF));
EU - Orphan Drug (Treat cystic fibrosis (CF))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today